Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 110-116

  Wu, Hongxu ^a   Yang, Shifang ^a,b   Wu, Xiaojie ^a   Zhao, Junling ^a   Zhao, Jianping ^a   Ning, Qin ^a   Xu, Yongjian ^a   Xie, Jungang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Chronic obstructive pulmonary disease; Interleukin 33; Mouse models; Peripheral blood mononuclear cells

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CIGARETTE SMOKE; INTERLEUKIN 33; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; MESSENGER RNA; ORPHAN RECEPTOR ST2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIAL ENDOTHELIAL CELL; BRONCHUS; CELL STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PASSIVE SMOKING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATION;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; INTERLEUKIN-33; MOUSE MODELS; PERIPHERAL BLOOD MONONUCLEAR CELLS;

ANIMALS; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; MALE; MICE; MICE, INBRED C57BL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, INTERLEUKIN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TOBACCO SMOKE POLLUTION;

EID: 84904649654     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.05.073     Document Type: Article

References (27)

1. D.M. Mannino, and A.S. Buist Global burden of COPD: risk factors, prevalence, and future trends Lancet 370 2007 765 773
2. R. Aldonyte, L. Jansson, E. Piitulainen, and S. Janciauskiene Circulating monocytes from healthy individuals and COPD patients Respir. Res. 4 2003 11
3. M.G. Cosio, and J. Majo Inflammation of the airways and lung parenchyma in COPD: role of T cells Chest 121 2002 160S 165S
4. C.E. Bolton, A.A. Ionescu, K.M. Shiels, R.J. Pettit, P.H. Edwards, M.D. Stone, L.S. Nixon, W.D. Evans, T.L. Griffiths, and D.J. Shale Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 170 2004 1286 1293
5. R. Sabit, C.E. Bolton, P.H. Edwards, R.J. Pettit, W.D. Evans, C.M. McEniery, I.B. Wilkinson, J.R. Cockcroft, and D.J. Shale Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 175 2007 1259 1265
6. D.D. Sin, and S.F. Man Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality Proc. Am. Thorac. Soc. 2 2005 8 11
7. T.M. Eagan, T. Ueland, P.D. Wagner, J.A. Hardie, T.E. Mollnes, J.K. Damas, P. Aukrust, and P.S. Bakke Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Eur. Respir. J. 35 2010 540 548
8. V.M. Pinto-Plata, H. Mullerova, J.F. Toso, M. Feudjo-Tepie, J.B. Soriano, R.S. Vessey, and B.R. Celli C-reactive protein in patients with COPD, control smokers and non-smokers Thorax 61 2006 23 28
9. C.A. Dinarello An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor Immunity 23 2005 461 462
10. J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, T.K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, D.M. Gorman, J.F. Bazan, and R.A. Kastelein IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
11. V. Carriere, L. Roussel, N. Ortega, D.A. Lacorre, L. Americh, L. Aguilar, G. Bouche, and J.P. Girard IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo Proc. Natl. Acad. Sci. U.S.A. 104 2007 282 287
12. F.Y. Liew, N.I. Pitman, and I.B. McInnes Disease-associated functions of IL-33: the new kid in the IL-1 family Nat. Rev. Immunol. 10 2010 103 110
13. Y. Kondo, T. Yoshimoto, K. Yasuda, S. Futatsugi-Yumikura, M. Morimoto, N. Hayashi, T. Hoshino, J. Fujimoto, and K. Nakanishi Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system Int. Immunol. 20 2008 791 800
14. C. Qiu, Y. Li, M. Li, X. Liu, C. McSharry, and D. Xu Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice Immunology 138 2013 76 82
15. F. Garcia-Rio, M. Miravitlles, J.B. Soriano, L. Munoz, E. Duran-Tauleria, G. Sanchez, V. Sobradillo, and J. Ancochea Systemic inflammation in chronic obstructive pulmonary disease: a population-based study Respir. Res. 11 2010 63
16. C.M. Lloyd IL-33 family members and asthma - bridging innate and adaptive immune responses Curr. Opin. Immunol. 22 2010 800 806
17. D.E. Smith IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma Clin. Exp. Allergy 40 2010 200 208
18. W.Q. Gan, S.F. Man, A. Senthilselvan, and D.D. Sin Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Thorax 59 2004 574 580
19. T.M. Eagan, E.C. Gabazza, C. D'Alessandro-Gabazza, P. Gil-Bernabe, S. Aoki, J.A. Hardie, P.S. Bakke, and P.D. Wagner TNF-alpha is associated with loss of lean body mass only in already cachectic COPD patients Respir. Res. 13 2012 48
20. K. Al-shair, U. Kolsum, R. Dockry, J. Morris, D. Singh, and J. Vestbo Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD Respir. Res. 12 2011 3
21. F. Maltais, A.A. Simard, C. Simard, J. Jobin, P. Desgagnes, and P. LeBlanc Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD Am. J. Respir. Crit. Care Med. 153 1996 288 293
22. A. Agusti Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should) Proc. Am. Thorac. Soc. 4 2007 522 525
23. L.M. Fabbri, and K.F. Rabe From COPD to chronic systemic inflammatory syndrome? Lancet 370 2007 797 799
24. D. Xu, W.L. Chan, B.P. Leung, F. Huang, R. Wheeler, D. Piedrafita, J.H. Robinson, and F.Y. Liew Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells J. Exp. Med. 187 1998 787 794
25. J. Lin, L. Zhang, G. Zhao, Z. Su, R. Deng, S.C. Pflugfelder, and D.Q. Li A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium PLoS ONE 8 2013 e60963
26. A. Weber, P. Wasiliew, and M. Kracht Interleukin-1 (IL-1) pathway Sci. Signal. 3 2010 cm1
27. D. Prefontaine, S. Lajoie-Kadoch, S. Foley, S. Audusseau, R. Olivenstein, A.J. Halayko, C. Lemiere, J.G. Martin, and Q. Hamid Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells J. Immunol. 183 2009 5094 5103